Scientist / musician discovers resonant frequencies can be tuned to kill cancer – Anthony Holland / TED

Sympathetic resonant vibration

Anthony Holland: Associate Professor, Director of Music Technology, Skidmore College. DMA, MM, MM, BM; President: Novobiotronics Inc. [a nonprofit 501(c)(3) charitable and educational company]. Discovered the ability of Oscillating Pulsed Electric Fields (OPEF) to destroy cancer cells and MRSA in laboratory experiments. Expert in custom digital electronic signal design, synthesis and analysis for biological effects. Member: Bioelectromagnetics Society (BEMS), European Bioelectromagnetics Association (EBEA). Postdoctoral work: Center for Computer Research in Music and Acoustics (CCRMA) Stanford University. Advanced Digital Synthesis and Analysis studies with: Max Mathews (the ‘ Father of Computer Music’), John Chowning (founding Director of CCRMA, Electronic Composer and Inventor (famed FM Synthesis Patent); Jean-Claude Risset (Electronic Composer and founding Director of the Digital Synthesis Division of the internationally renowned IRCAM center, Paris, France); John Pierce: former Director of Sound Division: Bell Laboratories.

Note original presentation was 2013.  Ten years on and ignored if not outright suppressed.

“We turn on our electronic signals, and the tumor shrinks or is broken up.” — 15:25 in

100 kHz – 300 kHz useful frequency range


Anthony Holland’s Breakthrough in Cancer Research: Harnessing Oscillating Pulsed Electric Fields (OPEF)

In the realm of medical breakthroughs, the discovery of new treatments and therapies is always a cause for hope and celebration. One such innovator making waves in cancer research is Dr. Anthony Holland, whose groundbreaking work with Oscillating Pulsed Electric Fields (OPEF) has shown remarkable potential in destroying cancer cells and combating antibiotic-resistant bacteria like MRSA.

Dr. Holland, a musician and inventor turned biomedical researcher, has dedicated his career to exploring the intersection of sound, resonance, and biology. His journey into the world of OPEF began with a deep curiosity about the power of frequencies to influence living organisms. Drawing inspiration from the principles of resonance and vibrational medicine, Dr. Holland embarked on a mission to harness the therapeutic potential of electrical and sound waves.

His pioneering experiments, conducted at the Novobiotronics Research Institute, have yielded groundbreaking results. Dr. Holland’s research demonstrates that specific frequencies of OPEF can selectively target and destroy cancer cells while leaving healthy cells unharmed. This targeted approach holds immense promise for developing non-invasive and precision-based cancer treatments that minimize side effects and improve patient outcomes.

One of the most compelling aspects of Dr. Holland’s work is its potential to address antibiotic resistance, a growing global health concern. By applying OPEF technology, Dr. Holland and his team have successfully eradicated MRSA (Methicillin-resistant Staphylococcus aureus) bacteria in laboratory settings. This achievement opens new avenues for combating drug-resistant infections and enhancing the effectiveness of antimicrobial therapies.

The mechanism behind OPEF’s effectiveness lies in its ability to disrupt the membrane integrity of cancer cells and bacteria through controlled electrical pulses. By modulating the frequency and intensity of these pulses, researchers can target specific cellular structures and trigger cell death, a process known as apoptosis.

While Dr. Holland’s work is still in the experimental stages, the potential implications are profound. OPEF technology offers a glimpse into a future where personalized and innovative therapies revolutionize cancer treatment and infectious disease management. Furthermore, the non-invasive nature of OPEF-based interventions could reduce the burden of invasive procedures and improve the quality of life for patients undergoing treatment.

As Dr. Holland continues to refine and expand his research, the medical community eagerly anticipates the translation of OPEF technology from the laboratory to clinical applications. With ongoing advancements in biotechnology and biomedical engineering, the prospect of harnessing the power of oscillating pulsed electric fields to combat cancer and antibiotic-resistant infections represents a beacon of hope in the quest for transformative medical solutions.

Leave a Comment